Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | OXTR | P30559 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17879344 | 0.99 | AVPR1A (0.50) | AVPR1AHPGDSMN1; SMN2GLAOXTR | |
| SCHEMBL22002604 | 0.89 | AVPR1A (0.42) | AVPR1AHPGDSMN1; SMN2GLAOXTR | |
| SCHEMBL17536166 | 0.86 | AVPR1A (0.59) | AVPR1AHPGDSMN1; SMN2GLAOXTR | |
| SCHEMBL29362431 | 0.86 | AVPR1A (0.59) | AVPR1AHPGDSMN1; SMN2GLAOXTR | |
| SCHEMBL17879369 | 0.85 | AVPR1A (0.56) | AVPR1AHPGDSMN1; SMN2GLAOXTR | |
| SCHEMBL17951539 | 0.85 | AVPR1A (0.56) | AVPR1AHPGDSMN1; SMN2GLAOXTR | |
| SCHEMBL23085303 | 0.84 | HPGD (0.39) | AVPR1AHPGDSMN1; SMN2GLAOXTR | |
| SCHEMBL19321560 | 0.81 | TYMS (0.42) | AVPR1AHPGDKDM4EALDH1A1HSD17B10 | |
| SCHEMBL20383156 | 0.80 | ESR1 (0.54) | HPGDSMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL19321547 | 0.80 | TYMS (0.40) | AVPR1AHPGDKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210074927-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | KYULUX, INC. (JP) | 2021-03-11 | — | — | US | disclosed |
| US-10862047-B2 | Organic electroluminescent device | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2020-12-08 | — | — | US | disclosed |
| US-10658596-B2 | — | — | 2020-05-19 | — | — | US | disclosed |
| US-20170213974-A1 | ORGANIC LIGHT-EMITTING DEVICE, HOST MATERIAL, LIGHT-EMITTING MATERIAL, AND COMPOUND | KYULUX, INC. (JP) | 2017-07-27 | — | — | US | disclosed |
| US-20170213974-A1 | ORGANIC LIGHT-EMITTING DEVICE, HOST MATERIAL, LIGHT-EMITTING MATERIAL, AND COMPOUND | KYULUX, INC. (JP) | 2017-07-27 | — | — | US | disclosed |
| US-20170163010-A1 | ORGANIC LIGHT-EMITTING ELEMENT | KYUSHU UNIVERSITY NATIONAL UNIVERSITY CORPORATION (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20170163010-A1 | ORGANIC LIGHT-EMITTING ELEMENT | KYUSHU UNIVERSITY NATIONAL UNIVERSITY CORPORATION (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20160190478-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2016-06-30 | — | — | US | disclosed |
| US-20160190478-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170213974-A1 | ORGANIC LIGHT-EMITTING DEVICE, HOST MATERIAL, LIGHT-EMITTING MATERIAL, AND COMPOUND | CRY1, CRY2, CYBA | AVPR1A 3302/4885HPGD 919/4885SMN1; SMN2 3376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.